文献速递流行病学与生物统计临床试验与 GCP

用历史对照数据补充临床试验:动态借用的前景是幻觉吗?

Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?
PubMed 文献 · Stat Med · 2016-12-07

本文讨论用历史对照数据补充新试验证据时,折扣程度难以确定的问题,指出若对偏倚参数方差无强假设(即动态借用),历史数据在频率学派或贝叶斯框架下均可能无增益,并基于均方误差提出一种图形工具,以肌萎缩侧索硬化试验历史数据示例不同假设可致不同结论。

要点

  • 历史信息相对新试验信息应降权或折扣,但合适折扣程度是主要难点。
  • 偏倚参数方差仅靠历史与新数据比较难以准确估计。
  • 若不对该方差做强假设(动态借用),历史数据可能几乎无增益。

核心结论

  • 若不对偏倚参数方差做强假设即实践动态借用,使用历史数据在频率学派或贝叶斯框架下可能几乎无增益。
  • 因此最好比较一系列假设的后果,不同假设可导致非常不同的结论。

研究设计与样本

  • 本文为方法学论文,提出基于均方误差的图形工具,并用肌萎缩侧索硬化临床试验的历史数据示例其用法。

主要发现

  • 历史与新数据比较只能给出偏倚参数方差的较差估计。
  • 不同假设可导致非常不同的结论。
  • 外部信息有时可提供强有力的额外指导,但不同利益相关者对合适折扣程度仍可能做出非常不同的判断。

局限性

  • 历史与新数据比较只能给出偏倚参数方差的较差估计。
  • 若不对偏倚参数方差做强假设即动态借用,历史数据可能几乎无增益。
  • 不同利益相关者对合适折扣程度仍可能做出非常不同的判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There are strong arguments, ethical, logistical and financial, for supplementing the evidence from a new clinical trial using data from previous trials with similar control treatments. There is a consensus that historical information should be down-weighted or discounted relative to information from the new trial, but the determination of the appropriate degree of discounting is a major difficulty. The degree of discounting can be represented by a bias parameter with specified variance, but a comparison between the historical and new data gives only a poor estimate of this variance. Hence, if no strong assumption is made concerning its value (i.e. if 'dynamic borrowing' is practiced), there may be little or no gain from using the historical data, in either frequentist terms (type I error rate and power) or Bayesian terms (posterior distribution of the treatment effect). It is therefore best to compare the consequences of a range of assumptions. This paper presents a clear, simple graphical tool for doing so on the basis of the mean square error, and illustrates its use with historical data from clinical trials in amyotrophic lateral sclerosis. This approach makes it clear that different assumptions can lead to very different conclusions. External information can sometimes provide strong additional guidance, but different stakeholders may still make very different judgements concerning the appropriate degree of discounting. Copyright © 2016 John Wiley & Sons, Ltd.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Galwey NW. Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion? Stat Med. 2016. PMID: 27925274. doi:10.1002/sim.7180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。